These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6110238)

  • 21. [Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
    Baumann J; Martschick R
    Med Welt; 1982 Jan; 33(4):139-41. PubMed ID: 7062844
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 24. Xanthinol nicotinate in peripheral vascular disease.
    Davis E; Rozov H
    Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of thermography and ultrasound dopplerography for evaluating efficacy of complamin in the treatment of patients with disorders of cerebral circulation].
    Kozlova EN; Nikitin IuM; Strel'tsova EN
    Klin Med (Mosk); 1981 Sep; 59(9):38-42. PubMed ID: 7311428
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinico-hemodynamic evaluation of the efficacy of vasoactive and cardiotonic agents in the combined treatment of arteriosclerosis patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1313-20. PubMed ID: 3425072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
    Mensen H
    Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 30. Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies.
    Afifi AM; Adnan M; Taha M; Amasha ME
    Curr Med Res Opin; 1979; 6(5):309-13. PubMed ID: 540521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 33. [Xanthinol nicotinate and bufenin hydrochloride in the treatment of gestosis].
    Cretti A; Jaworski S
    Ginekol Pol; 1976 Aug; 47(8):909-16. PubMed ID: 971859
    [No Abstract]   [Full Text] [Related]  

  • 34. Thermographical follow-up during treatment of chronic ulcerations with iontophoresis with xanthinol nicotinate.
    van der Kuy A; Aarts NJ
    Bibl Radiol; 1975; (6):203-9. PubMed ID: 1180851
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
    Komorovskaia IaM; Nechaĭ EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K; Djaja S; Richter E
    Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of cerebral embolism in heart surgery.
    Bross W; Bross T; Koltowski R; Kustrzyski A; Olejak B; Dymala L; Masiak M; Crzereda T; Kibler J; Krupacz R; Ostapczuk S; Michel AJ
    Ann Chir Gynaecol Fenn; 1975; 64(5):280-3. PubMed ID: 1211834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological properties and clinical use of xanthinol nicotinate].
    Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
    Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD
    Med Monatsschr; 1976 Apr; 30(4):178-80. PubMed ID: 958145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.